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Activation of the IL-1b-Processing Inflammasome Is
Involved in Contact Hypersensitivity
Hideki Watanabe1,5, Olivier Gaide1,5, Virginie Pe´trilli2, Fabio Martinon2,6, Emmanuel Contassot1,
Ste´phanie Roques1, Jean A. Kummer3, Ju¨rg Tschopp2 and Lars E. French4
The inflammasome is a cytosolic protein complex regulating the activation of caspase-1, which cleaves the
pro-inflammatory cytokines IL-1b and IL-18 into their active form. The inflammasome is composed of a NACHT-,
LRR- and pyrin (NALP) family member that acts as a sensor for danger signals and the adaptor protein apoptosis-
associated speck-like protein containing a CARD domain (ASC), which allows the recruitment of caspase-1 in
the complex. In the skin, exposure to contact sensitizers (CS) such as trinitro-chlorobenzene causes an immune
response called contact hypersensitivity (CHS) or eczema. In this delayed-type hypersensitivity response,
efficient priming of the adaptive immunity depends on the concomitant activation of the innate immune
system, including IL-1b/IL-18 activation in the skin. To determine if the inflammasome contributes to CHS, we
have analyzed its capacity to react to CS in vitro and in vivo. We show here that key components of the
inflammasome are present in human keratinocytes and that CS like trinitro-chlorobenzene induce caspase-1/
ASC dependent IL-1b and IL-18 processing and secretion. We also show that ASC- and NALP3-deficient mice
display an impaired response to CS. These findings suggest that CS act as danger signals that activate the
inflammasome in the skin, and reveal a new role of NALP3 and ASC as regulators of innate immunity in CHS.
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INTRODUCTION
The skin protects us from our environment and is therefore
constantly subjected to microbial, chemical, and physical
insults that ultimately result in the generation of non-self
antigens. Accordingly, the skin is endowed with the capacity
to trigger immune responses (Murphy et al., 2000). Sensitiz-
ing chemicals that penetrate the skin surface induce a
delayed-type hypersensitivity reaction called contact hyper-
sensitivity (CHS) (Grabbe and Schwarz, 1998). There are few
T cells in normal skin and antigen presentation occurs mostly
in draining lymph nodes. Uptake, transport, and presentation
of antigens is achieved primarily by specialized skin cells
called Langerhans cells (LCs) (Grabbe and Schwarz, 1998).
Efficient LC migration and antigen presentation as well as the
later recruitment of primed lymphocytes to the skin is
dependent on the concomitant presence of pro-inflammatory
stimuli (like IL-1b) induced by the contact sensitizers (CS)
themselves (Grabbe et al., 1996; Griffiths et al., 2005).
However, how sensitizing chemicals induce activation of
these cytokines is still unknown.
IL-1b and IL-18 mediate acute inflammatory responses and
provide a link between innate and adaptive immunity in CHS
(Shornick et al., 1996; Wang et al., 2002). Both cytokines are
produced as inactive cytoplasmic precursors, which are
processed into their active forms by caspase-1 (Cerretti et al.,
1992; Thornberry et al., 1992; Ghayur et al., 1997; Dinarello,
1998). Interestingly, a functional caspase-1 was found to be
necessary for LC migration and optimal CHS in mice
(Antonopoulos et al., 2001). The molecular mechanisms
controlling caspase-1 activity were totally unknown until
very recent studies demonstrated that it relied on a cytosolic
multiprotein complex composed of a NACHT-, LRR-, and
pyrin domain (NALP) family member, the protein apoptosis-
associated speck-like protein containing a CARD (ASC) and
caspase-1 (Srinivasula et al., 2002; Agostini et al., 2004;
Martinon and Tschopp, 2005). As this complex regulates pro-
inflammatory cytokine activation, it was given the name
inflammasome (Martinon and Tschopp, 2004).
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The role of the 14 human NALP proteins identified is still
poorly understood. NALPs form a subfamily of the NACHT-
LRR family that includes nucleotide oligomerisation domain
(NOD) proteins and is reminiscent of Toll-like receptors
(Martinon and Tschopp, 2005). Interestingly, the latter are
key sensors of the innate immune system that detect
pathogen-associated molecular patterns (Akira and Takeda,
2004). Recent studies using mice deficient in NALP3 or ASC
show that NALPs may sense bacterial components and uric
acid crystals. Upon exposure to these ‘‘danger signals’’, they
induce ASC-mediated caspase-1 recruitment and activation,
thereby triggering an inflammatory response (Kanneganti
et al., 2006; Mariathasan et al., 2006; Martinon et al., 2006).
Hence, NALPs complete the NOD and toll-like receptors
(TLR) repertoire of danger sensors.
Mutations in the gene encoding NALP3 are associated
with severe auto-inflammatory disorders characterized by
recurrent fevers owing to excessive IL-1b secretion that are
alleviated by IL-1 receptor antagonists (Hawkins et al., 2003;
Agostini et al., 2004; Hoffman et al., 2004). This underlines
the central role of the inflammasome in IL-1b regulation and
the necessity to tightly control its activity. As patients affected
by these diseases have inflammatory skin lesions, we
hypothesized that an active inflammasome is present in the
skin and that it may be responsible for CS-mediated IL-1b
activation. We show here that the inflammasome is indeed
present and can be activated in keratinocytes. Moreover,
ASC- and NALP3-deficient mice display an impaired CHS to
trinitro-chlorobenzene (TNCB) and dinitro-1-fluorobenzene
(DNFB), thus identifying the NALP3 inflammasome as a key
regulator of innate immunity in contact hypersensitivity.
Hence, pro-inflammatory signals necessary for the priming of
T cells are provided, at least in part, by danger sensors of the
NALP family.
RESULTS
TNCB, SDS, and UV induce caspase-dependent IL-1b secretion
by keratinocytes
Evidence suggests that several cytokines implicated in CHS
are produced by resident cells within the skin (Grabbe et al.,
1996; Griffiths et al., 2005). In particular, LC and keratino-
cytes can secrete IL-1b and IL-18 upon exposure to CS (Enk
et al., 1993; Naik et al., 1999) and these cytokines are crucial
for LC migration to the lymph nodes (Cumberbatch et al.,
2002). We decided to determine if keratinocytes, which form
the major cell population in the skin, could react to danger
signals by activating and secreting IL-1b. In macrophages,
IL-1b secretion follows two sequential events: (i) upregulation
of pro-IL-1b through NF-kB-mediated transcriptional activa-
tion (Martinon and Tschopp, 2005) and (ii) inflammasome/
caspase-1-mediated processing of pro-IL-1b (Dinarello, 1998;
Martinon et al., 2002). We found that exposure of primary
keratinocytes to purified flagellin (activating TLR5), MALP-2
(activating TLR6), or TNFa, which all activate NF-kB indeed
resulted in an increase of the expression level of pro-IL-1b
(Figure 1a and data not shown). The promoter of pro-IL-1b
is known to contain an NF-kB binding site (Hiscott et al.,
1993), and other potent NF-kB activators are therefore likely
to have a similar effect on cultured keratinocytes. This
increase in pro-IL-1b was not paralleled by a significant rise
in IL-1b secretion (Figure 1b). However, significant secretion
of IL-1b could be induced by exposure to the CS TNCB,
DNFB, and dinitro-1-chlorobenzene. Likewise, SDS and UVB
significantly increased IL-1b secretion, whereas UVA induced
only a minor increase in IL-1b levels. IL-1b secretion was
dependent on caspase activity, as it was blocked by the pan-
caspase inhibitor benzyloxycarbonyl-valine-alanine-aspartate
(zVAD) (Figure 1b). Apoptosis was not observed at these
doses of TNCB and UV, suggesting that caspase-1 may be
involved. In accordance with this, targeted overexpression of
caspase-1 in mouse keratinocytes was shown to result in CHS
symptoms dependent on IL-1b and IL-18 (Yamanaka et al.,
2000). Keratinocytes can thus sense danger signals and
subsequently activate IL-1b independently of the immune
system. Although TNF prestimulation allowed an easier
detection of IL-1b, it was not essential for its activation and
secretion (Figure 3a).
Both keratinocytes and monocyte-derived cells contain
molecular components required for inflammasome assembly
In macrophages, pro-IL-1b processing is dependent on the
assembly of the inflammasome, composed of a NALP protein,
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Figure 1. Danger signals induce caspase-dependent IL-1b secretion by
keratinocytes. (a) Stimulation of primary keratinocytes by NF-kB activators
such as TLR5/6 or TNFa (100 ng/ml) results in an increase in pro-IL-1b
expression levels. (b) Exposure to TNFa itself does not result in a significant
secretion of IL-1b, but TNFa-pretreated cells respond to TNCB (0.1, 1, and
5mg/ml), SDS (15 mg/ml), or UVB (80 mJ/cm2) for 24 hours by secreting IL-1b
in the supernatant (ELISA detection, nX6), as opposed to stimulation by
UVA (80 mJ/cm2) exposure. In each case, IL-1b secretion is blocked by the
pan-caspase inhibitor zVAD (20 mM).
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the adaptor protein ASC, and caspase-1, which cleaves it
directly (Dinarello, 1998; Martinon et al., 2002). We
reasoned that resident skin cells may use the same machinery
and assessed the presence of molecular components of the
inflammasome in keratinocytes and Langerhans-like cells.
Messenger RNA coding for all NALPs 1–6, 8, 10–11, and
13–14 were detectable in primary keratinocytes and human
adult calcium-reduced temperature elevated keratinocyte
(HaCaT) cells (Figure 2a). NALP7 was only detectable in
primary keratinocytes, whereas NALP12 could only be dete-
cted in HaCaT cells. Messenger RNA for all NALPs except
NALP 5, 7, and 9 were observed in Tohoku University,
Department of Pediatrics-1 (THP-1) cells, a monocyte-
derived cell line. Monocytes have the potential to differenti-
ate into dendritic cells and respond to sensitizers, thus
resembling LCs (Ashikaga et al., 2002). Messenger RNA for
ASC-1, caspase-1, caspase-5, pro-IL-1b, and IL-18 were
detectable in the three cell types (Figure 2b).
Expression at the protein level was confirmed by SDS-
PAGE/Western blot analysis of whole-cell proteins extracts.
NALP1 and NALP3, ASC, caspase-1 and caspase-5 could be
readily detected in primary keratinocytes, HaCaT cells, and
THP-1 cells (Figure 2c). Levels of NALP1, NALP3, and
caspase-1 were lower in keratinocytes than in THP-1 cells,
whereas levels of caspase-5 and ASC were similar. This
suggests that resident skin cells contain the molecular
components necessary for inflammasome assembly.
TNCB induces ASC-dependent caspase-1 and IL-1b activation
in keratinocytes
We next looked at the role of caspase-1 in TNCB-induced IL-
1b activation by exposing primary keratinocytes to TNCB and
analyzing the cellular and secreted caspase-1/IL-1b patterns.
Activated (cleaved) fragments of caspase-1 (p35 and p11), IL-
18 (p18), and IL-1b (p17) could be found in supernatants only
after TNCB stimulation (Figure 3a, supernatants). Pretreat-
ment with TNFa increased capase-1 cleavage and IL-1b
secretion as previously reported (Dinarello, 1998; Martinon
et al., 2002), but IL-18 activation was unchanged. This may
be explained by the observation that both caspase-1 and
pro-IL-1b expression levels are increased by TNFa but not
IL-18 (Figure 4a, cell extracts).
TNCB-induced caspase-1 cleavage resulted in a decrease
of the intracellular pool of full-length caspase-1 (Figure 3a,
cell extracts). Shorter fragments of capase-1 were not
detected in the cell extracts, which is consistent with previous
reports showing that cleaved caspase-1 is secreted together
with IL-1b (Martinon et al., 2002). The kinetic of caspase-1
(p35 and p11) and IL-1b activation, appearing 6 hours after
stimulation and increasing thereafter (Figure 3b and data not
shown), was similar in monocyte-derived cells stimulated
with uric acid crystals (Martinon et al., 2006). Concomitant
exposure to the caspase-1-specific inhibitor benzyloxycarbo-
nyl-tyrosine-valine-alanine-aspartate (zYVAD) blocked both
caspase-1 and IL-1b activation and secretion (Figure 3b).
Hence, TNCB-induced caspase-1 activation in keratinocytes
is necessary for IL-1b activation.
We confirmed the central role of the inflammasome by
isolating mouse keratinocytes from ASC-deficient mice and
exposing them to TNCB. ASC-deficient keratinocytes failed to
secrete IL-1b upon in vitro exposure to TNCB, in contrast to
keratinocytes isolated from wild-type mice (Figure 3c).
Hence, TNCB-induced IL-1b activation and secretion by
keratinocytes is likely to be controlled by the inflammasome.
Contact hypersensitivity to DNFB and TNCB is reduced
in ASC and NALP3-deficient mice
In order to confirm the role of the inflammasome in vivo, we
used a model of CHS to DNFB, where 6- to 7-week-old ASC-
deficient mice and their wild-type littermates were sensitized
either on the left ear or on their shaved belly and then
challenged on day 5 at a distant site (i.e. the right ear). Ear
thickness measured 24 hours after the challenge showed a
significant diminution of the ear swelling in ASC-deficient
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Figure 2. Keratinocytes and monocyte-derived cells contain the molecular components necessary for inflammasome activity. (a) Reverse transcription-PCR
analysis shows detectable levels of mRNA coding for most members of the NALP family in primary human keratinocytes (PK), keratinocyte-derived HaCaT
cells, and the monocyte-derived THP-1 cell line. (b) Messenger RNA of ASC, caspase-1, caspase 5, IL1-b, and IL-18 are present in primary keratinocytes
(PK), HaCaT, and THP-1 cells. (c) Western blot analysis reveals the presence of NALP1, NALP3, caspase-1, caspase-5, and ASC at the protein level in PK,
HaCaT, and THP-1 cells. The specificity of each antibody was confirmed by Western blot analysis of extracts from 293T cells transfected or not with the
relevant complementary DNAs. The data presented are representative of at least three independent experiments.
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mice (Figure 4a). In non-sensitized mice, DNFB failed to
induce a detectable ear swelling, as previously described
(Riemann et al., 2005). The limited ear swelling observed
after sensitization on the belly may be due to the ingestion (by
licking) of small amounts of DNFB, which acts as a tolerizer
when applied orally (Faria and Weiner, 2005).
Contact hypersensitivity (CHS) involves priming of naı¨ve
T cells (sensitization) and activation of primed T cells upon
re-exposure to the antigen (elicitation). Elicitation can be
subdivided into an early and a late phase (Grabbe and
Schwarz, 1998). The early phase, characterized by increased
vessel permeability and local edema, peaks 8 hours after
antigen re-exposure and is believed to be mediated by local
release of cytokines (including IL-1b) and histamine (Kitagaki
et al., 1997; Grabbe and Schwarz, 1998). The late phase
develops 12–36 hours after antigen re-exposure and is due to
cellular infiltration.
We examined both the early and late phases of TNCB-
induced CHS in IL-1R-, ASC-, and NALP3-deficient mice.
Mice 6–7 week old were sensitized twice to TNCB by
external application of TNCB on the ear at day 0 and 7, and
ear thickness was measured 1, 2, 3.5, 5, 8, 14, 24, 32, and
48 hours after elicitation with TNCB at day 14. Consistent
with previous reports, we observed a peak ear swelling
5–8 hours after TNCB application (early phase), followed by a
second peak at 24 hours (late phase) (Figure 4b). IL-1R defi-
ciency did not alter the kinetics, but resulted in a significant
decrease in the intensity of the ear swelling (Figure 4b and c).
In ASC- and NALP3-deficient animals, TNCB-induced
swelling was significantly lower in the early phase of
elicitation (Figure 4c). The extent of this reduction was
similar in ASC, NALP3, and IL-1R-deficient mice, although
strain differences (BALB/c, DBA/C57BL/6, and C57BL/6,
respectively) resulted in different peak levels in ear swellings,
as previously reported (Bigby et al., 1987). The reduction of
the ear swelling was confirmed by histological analysis of
ASC and NALP3 deficient mice ears 5 hours after TNCB
application, which revealed a marked reduction in the
swelling, subcutaneous edema, and vasodilatation that
normally characterize the early phase (Figure 5). The late
phase of elicitation, characterized by the recruitment of
inflammatory cells in the skin, was not significantly different
in ASC- and NALP3-deficient mice, suggesting that the
inflammasome only plays a minor role at this stage (Figure
4c and 5).
We found that IL-1R deficiency affected the early phase as
well as the late phase of elicitation, although the difference
observed was not always statistically significant (Figure 4b
and c). This either suggests that IL-1a in involved in the late
phase of elicitation (both IL-1a and b signal thought the IL-1R)
or that IL-1b can be cleaved by other proteases, such as mast
cells chymases (Mizutani et al., 1991). However, activation
of caspase-1 was demonstrated to be essential for optimal
sensitization in mice, suggesting that other proteases only
play a minor role in IL-1b activation in CHS (Antonopoulos
et al., 2001).
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Figure 3. TNCB induces ASC-dependent caspase-1 and IL-1b activation in keratinocytes. (a) Primary keratinocytes exposed to TNCB (5 mg/ml) secrete active
caspase-1 (p35 and p11), IL-18 (p18), and IL-1b (p17), as revealed by Western blot and ELISA analysis of supernatants (SN). This is paralleled by a decrease
in full-length caspase-1 found in cell extracts (CE). TNFa increases the expression levels of caspase-1 and pro-IL-1b but not IL-18 (CE). TNFa pretreatment
increases activation and secretion of both caspase-1 and IL-1b SN (b) Secretion of active caspase-1 (p35 and p11) in the supernatant (SN) and IL-1b (ELISA) starts
6 hours after TNCB exposure and is blocked by the caspase-1 inhibitor zYVAD (50 mM). (c) TNCB (1 mg/ml)-induced secretion of active IL-1b is reduced in
primary keratinocytes cultures derived from neonatal ASC-deficient (/) mice as opposed to wild-type (WT) mice.
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DISCUSSION
We provide evidence that primary human keratinocytes
contain the necessary elements to form an inflammasome
and that TNCB induces caspase-1-mediated cleavage and
activation of IL-1b in an ASC-dependent manner. The kinetics
of the activation of caspase-1 and IL-1b cleavage and
secretion was similar to the other inflammasome activators.
TNCB can thus be considered as a new ‘‘danger signal’’
sensed by the inflammasome, together with uric acid crystals
and ATP (Mariathasan et al., 2006; Martinon et al., 2006).
Interestingly, we found that other stimuli such as chemical
irritants (SDS) and physical agents (UVB) could also trigger
inflammasome activation, giving further support to the
hypothesis that mammals evolved a common set of sensors
for various danger signals, ranging form infections to physical
insults (Matzinger, 2002; Shi et al., 2003). It is unclear
whether the capacity to sense CS is a means of defense/alarm
or whether sensitizers ‘‘highjack’’ systems that have evolved
to sense other target molecules such as bacterial products. In
any case, inflammasome inhibitors may have the ability to
prevent inflammatory reactions owing to CS.
The importance of NALP3 and ASC in the early phase, and
not in the late phase, of elicitation suggests that the
inflammasome has little impact on the recruitment of primed
T cells, but rather initiates pro-inflammatory signals that
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Figure 5. Contact hypersensitivity to TNCB is reduced in ASC-deficient
mice. Histology of ASC-deficient and wild-type (wt) mice ears 5 hours after
TNCB challenge (bar¼ 200mm). Edema and vasodilatation characteristic of
the early phase of elicitation of CHS are less prominent in ASC-deficient
(/) mice as compared with wild-type littermates (þ /þ ). No apparent
histological difference is apparent 24 hours after elicitation with TNCB.
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promote T-cell priming. This is consistent with a recent report
showing that NALP3 is essential for the sensitization phase of
contact hypersensitivity to trinitrophenylchloride (Sutterwala
et al., 2006).
Low doses of CS are sufficient to stimulate pre-primed
T cells but insufficient to elicit a CHS response (Grabbe et al.,
1996), suggesting that in addition to hapten-specific recogni-
tion, a pro-inflammatory stimulus that is provided locally by
the contact sensitizer itself is necessary (Grabbe et al., 1996).
We propose that this pro-inflammatory stimulus is due to
NALP3 inflammasome-dependent IL-1b production in the
skin. However, other cytokines/signals are likely to modulate
the early phases of CHS, as IL-1R-deficiency did not totally
abrogate ear swelling after elicitation with TNCB. This may
be due at least in part to the presence of IL-18, which is also
activated by caspase-1 (Wang et al., 2002; Kawase et al.,
2003).
Our data suggest that keratinocytes stimulated by CS may
directly provide the pro-inflammatory stimuli required for
CHS. However, several other cells such as LC, dermal
dendritic cells, and mast cells were also reported to play a
role in CHS (Kitagaki et al., 1997; Griffiths et al., 2005;
Kaplan et al., 2005), and inflammasome activity in these cells
also be implicated. Interestingly, NOD2, which plays an
essential role in inflammatory bowel disease, is expressed at
low levels in normal enterocytes, but is induced by TNFa in
inflammatory conditions (Rosenstiel et al., 2003). We found
likewise that TNFa significantly increases some of the
inflammasome components in keratinocyte. This increase
was neither sufficient nor essential for IL-1b activation and
secretion, although it potentiated the effect of CS. Interest-
ingly, TNFa has been demonstrated to play a crucial role in
the cross-talk between LC and keratinocytes that drives LC
migration (Cumberbatch et al., 2003; Griffiths et al., 2005).
Taken together, these data suggest an active role of epithelial
cells, enterocytes, and keratinocytes in the surveillance of
danger signals and the activation of innate immunity signals.
Blocking of NF-kB signaling using topical decoy oligonu-
cleotide was recently reported to diminish symptoms of
atopic dermatitis in a mouse model of this disease (Dajee
et al., 2006). Although this effect may not be related to a
decrease in pro-IL-1b levels, it suggests that targeting the
inflammasome with small-molecule inhibitors (which remain
to be discovered) may represent a new modality for the
treatment of CHS. The characterization of the role of the
inflammasome in inflammatory skin disorders must be
therefore be pursued as it may eventually lead to develop-
ment of new treatment modalities for inflammatory skin
diseases.
MATERIALS AND METHODS
Cell culture
Primary keratinocytes (HEK, Biocoba, Basel, Switzerland) were
cultured in Epilife supplemented with the provided human
keratinocyte growth supplement and 60 mM of Caþþ and HaCaT
in DMEM:F-12 (1:1) (Invitrogen, NV Leeks, The Netherlands)
supplemented with 5mg/ml human insulin, 10 ng/ml cholera toxin,
0.4 mg/ml hydrocortisone, 10 ng/ml of human epidermal growth
factor, and 10% fetal calf serum. THP-1 cells were cultured in RPMI-
1640 medium (Invitrogen, NV Leeks, The Netherlands) containing
2 105 M of b-mercapto-ethanol and 10% fetal calf serum. Cell
cultures were maintained at 371C in humidified incubators with 5%
CO2. All media contained 100 U/ml of penicillin and 10 mg/ml of
streptomycin. Purified flagellin (activating TLR5) and MALP-2
(activating TLR6) from the TLR activating kit (Alexis, Lausen,
Switzerland) were used at 2 mg/ml. TNFa (human recombinant
TNFa, Alexis, Lausen, Switzerland) was used at 1 mg/ml. zVAD and
zYVAD (Alexis, Lausen, Switzerland) were used at a final concen-
tration of 20mM each. Mouse primary keratinocyte were obtained
from 2-day-old mice as described (Pirrone et al., 2005). Briefly,
whole skins were floated overnight in 0.25% trypsin at 41C. After
mechanical separation from the dermis, the epidermis was
dissociated by 50 shakes in a 15-ml tube in 5 ml of medium.
Keratinocytes were seeded in 50% low calcium fibroblast-condi-
tioned medium (EMEM, Cambrex, Verviers, Belgium) and preincu-
bated for 24 hours on dermal cells and 50% Epilife (Biocoba, Basel,
Switzerland) on collagen IV-coated dishes (non-keratinocyte will not
adhere/grow in these conditions) for 7 days before stimulation with
TNCB or DNFB or 4,6-dinitro-1-chlorobenzene at 1–10 mg/ml.
Reverse transcription-PCR
Total RNA extracted from fresh THP-1, HaCaT, and primary
keratinocytes using TRIzol reagent (Invitrogen, LV Leeks, The
Netherlands) was reverse-transcribed and amplified using OneStep
RT-PCR kit (Qiagen, Basel, Switzerland) according to the manufac-
turer’s instructions. Sequences of the oligonucleotide used for RT-
PCR are provided online in Table S1.
Western blot analysis and ELISA
Cell lysates and supernatants were subjected to SDS-PAGE/Western
blotting as described (Agostini et al., 2004). Primary antibodies:
human cleaved IL-1b (D116 epitope, Cell Signaling, Danvers),
human proIL-1b (R&D Systems, Abingdon, UK), human ASC/Pycard,
NALP1 and 3 (Apotech, Epalinges, Swizerland), human caspase-1
(Santa Cruz Biotechnology, LabForce AG, Nunningen, Switzerland),
or human caspase-5 (MBL, LabForce AG, Nunningen, Switzerland).
Secondary antibodies: horseradish peroxidase-conjugated anti-rabbit
or anti-mouse IgG (Jackson immunoresearch, Milan Analytica, La
Roche, Switzerland). Detection: ECL (Amersham, Zurich, Switzer-
land) as described in the manufacturer’s instructions. ELISA:
undiluted cell culture supernatants were subjected to human IL-1b
detection by ELISA (BD biosciences, Basel, Switzerland) according
to the manufacturer’s instructions.
Analysis of CHS in IL-1R, ASC, and NALP3 mice
Mice experiments were approved by the Geneva Cantonal
Veterinary Office before being conducted, according to institutional
and Swiss Federal Veterinary Office guidelines. IL-1R- and ASC-
deficient mice were obtained from M Kopf (Molecular Biomedicine
ETH, Zurich, Switzerland) and VM Dixit (Genentech, San Francisco,
CA). NALP3-deficient mice were generated as described (Martinon
et al., 2006). Mice (7–8 week old) (n¼ 5 per group) were sensitized
by external applications of 20 ml of 0.5% DNFB in acetone:olive oil
(3:1, v/v) on the left ear or on their shaved belly at days 0 and 1. At
day 5, sensitized mice were elicited on the ventral and dorsal side of
the right ear by topical application of 10 ml of 0.3% DNFB in
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acetone:olive oil. Ear thickness was measured 24 hours after
elicitation with a digital gauge (Mitsutoyo, Kanagawa, Japan) on
both ears. Alternatively, 6- to 7-week-old mice (X3 per group) were
sensitized by external applications of 20 ml of 1% TNCB in acetone
on the right ear at days 0 and 7. On day 14, ear thickness was
measured before and after TNCB application (20 ml of 1% TNCB in
acetone) to the same ear.
Statistical analysis
Groups were compared using one-tailed Student’s or Aspin–Welch’s
t-tests.
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